Hematopoietic Stem Cell Transplantation
174
31
35
79
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
14 trials with published results (8%)
Research Maturity
79 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.7%
3 terminated out of 174 trials
96.3%
+9.8% vs benchmark
11%
20 trials in Phase 3/4
18%
14 of 79 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 79 completed trials
Clinical Trials (174)
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
Xiaochaihu Granules for Depression After Allogeneic Hematopoietic Stem Cell Transplantation
Immunomonitoring After Hematopoietic Stem Cell Transplantation
HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT
Peer Support Intervention for Caregivers of Patients Undergoing HSCT
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Oral, Chemosensory and Trigeminal Functions in Allo-HSCT
Glucose Control In Hematopoetic Stem Cell Transplant
Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients